Grants per year
Fingerprint
Dive into the research topics where Ali Zhang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 5 Finished
-
Targeted Inhibition of EZH2 and BET BRD4 for the treatment of AT/RT
Hashizume, R. (PD/PI) & Zhang, A. (Co-Investigator)
7/1/19 → 8/31/20
Project: Research project
-
Epigenetic Targeted Therapy and Resistance in Pediatric Rhabdoid Tumor
Hashizume, R. (PD/PI) & Zhang, A. (Co-Investigator)
2/1/19 → 1/31/21
Project: Research project
-
Targeted Inhibition of EZH2 and BET BRD4 for the treatment of AT/RT
Hashizume, R. (PD/PI) & Zhang, A. (Co-PD/PI)
7/1/18 → 6/30/19
Project: Research project
-
Epigenetic targets of histone bromodomain and demethylase in DIPG therapy
Hashizume, R. (PD/PI) & Zhang, A. (Co-Investigator)
7/1/16 → 6/30/17
Project: Research project
-
Epigenetic targets of histone bromodomain and demethylase in DIPG therapy
Hashizume, R. (PD/PI) & Zhang, A. (Co-PD/PI)
Bear Necessities Pediatric Cancer Foundation
7/1/16 → 6/30/17
Project: Research project
-
Pleckstrin-2 Mediates the Activation of AKT in Prostate Cancer and Is Repressed by Androgen Receptor
Han, X., Zhang, A., Wang, P., Bi, H., Ren, K., Li, E., Yang, X., Aydemir, I., Tao, K., Lin, J., Abdulkadir, S. A., Yang, J. & Ji, P., Oct 2024, In: American Journal of Pathology. 194, 10, p. 1986-1996 11 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model
Zhang, S., Graeme Black, R., Kohli, K., Hayes, B. J., Miller, C., Koehne, A., Schroeder, B. A., Abrams, K., Schulte, B. C., Alexiev, B. A., Heimberger, A. B., Zhang, A., Jing, W., Ng, J. C. K., Shinglot, H., Seguin, B., Salter, A. I., Riddell, S. R., Jensen, M. C. & Gottschalk, S. & 3 others, , Jun 2022, In: Molecular cancer therapeutics. 21, 6, p. 999-1009 11 p.Research output: Contribution to journal › Article › peer-review
Open Access17 Scopus citations -
Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors
Ishi, Y., Zhang, Y., Zhang, A., Sasaki, T., Piunti, A., Suri, A., Watanabe, J., Abe, K., He, X., Katagi, H., Bhalla, P., Natsumeda, M., Zou, L., Shilatifard, A. & Hashizume, R., May 2022, In: Molecular cancer therapeutics. 21, 5, p. 715-726 12 p.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations -
Erratum: Activation of MAPK signaling by CXCR7 leads to enzalutamide resistance in prostate cancer (Cancer Research (2019) 79 (2580–2592) DOI: 10.1158/0008-5472.CAN-18-2812)
Li, S., Fong, K. W., Gritsina, G., Zhang, A., Zhao, C., Kim, J., Sharp, A., Yuan, W., Aversa, C., Yang, X. J., Nelson, P. S., Feng, F. Y., Chinnaiyan, A. M., de Bono, J. S., Morrissey, C., Rettig, M. B. & Yu, J., May 2020, In: Cancer Research. 80, 10, p. 2072 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access1 Scopus citations -
Activation of MAPK Signaling by CXCR7 leads to enzalutamide resistance in prostate cancer
Li, S., Fong, K. W., Gritsina, G., Zhang, A., Zhao, J. C., Kim, J., Sharp, A., Yuan, W., Aversa, C., Yang, X. J., Nelson, P. S., Feng, F. Y., Chinnaiyan, A. M., De Bono, J. S., Morrissey, C., Rettig, M. B. & Yu, J., 2019, In: Cancer Research. 79, 10, p. 2580-2592 13 p.Research output: Contribution to journal › Article › peer-review
Open Access90 Scopus citations